While many were anxious to accept initial findings showing a drug known as Targretin’s “too good to be true” lab results with Alzheimer’s disease, subsequent attempts to confirm and replicate the original data regarding the ability of Targretin to remove amyloid plaques, the cardinal lesion of the disease, have largely ...
May 24, 2013
The path from research discovery to drug development can be a long one. Current estimates target the time for an Alzheimer’s drug to get to market at around 12 years. However, with new technological advances in such areas as genetics, we are optimistic that scientific opportunities have never been greater to ...
August 20, 2009
November 14, 2018
Lisa Husted founded her company to provide comfort to those whose hearts are full of emotion and to grant them permission to cry in happy times and difficult times. The original design of the REMEMBRANCE handkerchief depicts two grey doves nestled among forget-me-nots, amidst a background of tiny blue dots. ...
October 30, 2020
Contact us about supporting Cure Alzheimer’s Fund at: Email: [email protected] Cure Alzheimer’s Fund is a “doing business as” name for the Alzheimer’s Disease Research Foundation, a 501(c)(3) public charity with federal tax ID #52-239-6428. Please note that your information will be used only by Cure Alzheimer’s Fund to record and acknowledge this ...
September 24, 2017
Washington, May 14, 2008 – Mapping the sequence of the genes susceptible to Alzheimer’s disease provides a novel avenue for potential treatment while also improving the ability to predict risk for Alzheimer’s early in life, Dr. Rudolph Tanzi, chairman of the Cure Alzheimer’s Fund Research Consortium, told the Senate Special ...
May 14, 2008
A stem cell model of familial Alzheimer’s disease (FAD) was successfully generated in a recent study, allowing researchers to identify 14 genes potentially implicated in the disease. One gene in particular demonstrates the important role inflammation may play in the brain of Alzheimer’s patients. The study was completed by scientists ...
January 8, 2014
In an effort to support the next generation of leading Alzheimer’s researchers, the Cure Alzheimer’s Fund has joined with the Alzheimer’s Association and the Lou Ruvo Brain Institute to create and fund a new “genius grant” for young Alzheimer’s researchers. he new prize called Tomorrow’s Leaders in Alzheimer’s Disease Research honors ...
June 15, 2007
In an effort to support the next generation of leading Alzheimer’s researchers, the Cure Alzheimer’s Fund has joined with the Alzheimer’s Association and the Lou Ruvo Brain Institute to create and fund a new “genius grant” for young Alzheimer’s researchers. The new prize called Tomorrow’s Leaders in Alzheimer’s Disease Research honors ...
February 19, 2007
Co-chaired by three members of CAF’s Research Consortium—Drs. David Holtzman, Sam Sisodia and Rudy Tanzi—participants included all the other members of the Research Consortium (except Virginia Lee, who had a prior commitment) and several invited guests whose records of research include valuable insights into this relationship. The guests were Michael ...
April 21, 2010
